Highbridge Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
2018
Q1
$5.26M Buy
2017
Q4
$4.93M Buy
2017
Q3
$2.58M Buy
2017
Q1
Sell
2016
Q4
$355K Buy